Chronic myeloid leukemia in 2006: a perspective

Haematologica. 2006 Feb;91(2):152.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Benzamides
  • Fusion Proteins, bcr-abl / antagonists & inhibitors
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / therapy
  • Neoplasm, Residual / therapy
  • Piperazines / therapeutic use
  • Pyrimidines / therapeutic use

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Fusion Proteins, bcr-abl